Equity Capital And Reserves Cambiamento Data
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
ALKERMES USD 1.36B 75.15M 2023-09
Amgen USD 6.23B 1.42B 2023-12
Eisai JPY 861.67B 16.8B 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
Intra Cellular Therapies USD 591.42M 9.26M 2023-12
Neurocrine Biosciences USD 2B 149.1M 2023-09
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Supernus Pharmaceuticals USD 921.52M 9.32M 2023-12
UCB EUR 9.04B 22M 2023-06
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Marinus Pharmaceuticals Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.